SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending as the community anticipates upcoming earnings, with some analysts predicting the stock could double its market cap. Bullish sentiment abounds, with some traders drawing comparisons to other high-growth tech stocks. However, concerns about high valuation and potential for a post-earnings pullback remain discussion points.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is surging on news of a massive, multi-year AI cloud services agreement with Microsoft, driving significant community excitement. Investors are drawing parallels to similar deals in the sector, anticipating a substantial upside, while also highlighting the company's strategic positioning in the AI infrastructure space. The conversation also involves speculation around potential earnings catalysts and further expansion opportunities.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as traders discuss whether it's setting up for a similar breakout to Amazon, focusing on accumulation patterns and potential FOMO. Some investors are frustrated with the stock's recent performance despite positive earnings, while others see it as an undervalued long-term play, especially with upcoming events like the World Cup and Olympics.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

LCID is trending amid concerns about its financial health and the overall EV market, despite partnerships with Nvidia and Uber. The community is discussing potential dilution, comparing it unfavorably to Tesla, and questioning its long-term viability. Bearish sentiment seems to be dominating, with some anticipating further declines and new all-time lows.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a mix of factors, including reactions to a recent lawsuit against a former colleague and anticipation of upcoming earnings. The community is actively discussing the potential impact of these events, with some speculating about leaked results and others focused on technical analysis and potential price movements. Overall, the sentiment is mixed, with both bullish and bearish viewpoints expressed.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is trending following positive clinical data from its TERN-701 trial, selected for oral presentation at an upcoming hematology conference, driving speculation of a potential buyout. Community members are weighing the bullish data against a recent $300M shelf registration, debating short-squeeze potential versus dilution risks. The focus shifts to TERN's oncology program after the discontinuation of their GLP-1 candidate, with some viewing it as a streamlined path to acquisition.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

LLY is trending as investors digest recent news, including strong phase 3 data for its oral GLP-1 orforglipron and potential impacts from government negotiations on drug pricing. Community discussions revolve around the drug's potential, target prices, and the ongoing competition within the weight loss and diabetes markets. Some are also discussing potential deals in the sector.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to a volatile reaction to recent FDA feedback regarding its Huntington's disease treatment, AMT-130; while the company believes the FDA is aligned for accelerated approval, the agency has voiced concerns around data adequacy. The community is actively debating the FDA's shifting stance, potential delays, and the overall implications for the company's future, with some suggesting a possible buyout while some expect that $QURE is overvalued.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences ($ENVB) is trending due to community discussion around its low float, with many eyeing the stock for potential short squeeze opportunities similar to other recent runners. Speculation includes potential news catalysts and a possible shift in focus towards digital asset treasury strategies. Some investors are also highlighting the company's intellectual property and potential settlement opportunities with AbbVie.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to optimism surrounding AI-driven memory demand and expectations of a "super cycle" in the memory market, with analysts raising price targets. The community is discussing the potential for significant revenue growth and Micron's role as a key supplier to hyperscalers. Some are speculating on partnership announcements and the possibility of Micron reaching new price levels, while others express caution about a potential pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NEW YORK, Sept. 16, 2025 /PRNewswire/ -- <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=2884077450&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>,&nbsp;a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of five new single stock leveraged ETFs. All five funds are first-to-market strategies and will be listed on Cboe. The funds aim to deliver twice (200%) the daily performance of a specific underlying stock.Tradr launches:<ul style="list-style-type:disc;"><li>Tradr 2X Long CLSK Daily ETF (Cboe: <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=105076250&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fclsx&amp;a=CLSX">CLSX</a>) – tracks CleanSpark, Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">CLSK</a>)</li><li>Tradr 2X Long CRDO Daily ETF (Cboe: <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=3455063811&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fcrdu&amp;a=CRDU">CRDU</a>) – tracks Credo Technology (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">CRDO</a>)</li><li>Tradr 2X Long ENPH Daily ETF (Cboe: <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=1575172717&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fenpx&amp;a=ENPX">ENPX</a>) – tracks Enphase Energy, Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">ENPH</a>)</li><li>Tradr 2X Long GS Daily ETF (Cboe: <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=3793977040&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fgsx&amp;a=GSX">GSX</a>) – tracks Goldman Sachs Group, Inc. (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">GS</a>)</li><li>Tradr 2X Long U Daily ETF (Cboe: <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=1536935528&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Funx&amp;a=UNX">UNX</a>) – tracks Unity Software Inc. (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">U</a>)</li></ul>"Tradr has created some significant momentum over the past five months by listening to active traders and building funds that help them reflect their high conviction bullish views," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "We expect all five of these ETFs to be well-received by investors looking to trade a variety of industry leaders such as Goldman Sachs, Unity and CleanSpark."This latest launch follows last week's debut of six first-to-market leveraged single-stock ETFs:<ul style="list-style-type:disc;"><li>Tradr 2X Long APLD Daily ETF (<a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=2732509736&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Faplx&amp;a=APLX">APLX</a>) – tracks Applied Digital Corp. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">APLD</a>)</li><li>Tradr 2X Long NBIS Daily ETF (<a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=698020524&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fnebx&amp;a=NEBX">NEBX</a>) – tracks Nebius Group NV (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">NBIS</a>)</li><li>Tradr 2X Long JOBY Daily ETF (<a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=2633886819&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fjobx&amp;a=JOBX">JOBX</a>) – tracks Joby Aviation Inc. (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">JOBY</a>)</li><li>Tradr 2X Long NVTS Daily ETF (<a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=598083193&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fnvtx&amp;a=NVTX">NVTX</a>) – tracks Navitas Semiconductor Corp. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">NVTS</a>)</li><li>Tradr 2X Long PONY Daily ETF (<a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=309958354&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fponx&amp;a=PONX">PONX</a>) – tracks Pony AI Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">PONY</a>)</li><li>Tradr 2X Long VOYG Daily ETF (<a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=2703773969&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fvoyx&amp;a=VOYX">VOYX</a>) – tracks Voyager Technologies Inc. (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-first-mover-leveraged-etfs-on-clsk-crdo-enph-gs-and-u-302557249.html#financial-modal">VOYG</a>)</li></ul>In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia. With today's listings, Tradr's lineup has grown to 34 leveraged ETFs representing over $1.1 billion in assets under management. Tradr's strategies can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=422327067&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=2884077450&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>&nbsp;are designed for sophisticated investors and professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4510047-1&amp;h=422327067&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000753SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Tradr Launches First Mover Leveraged ETFs on CLSK, CRDO, ENPH, GS and U

Single-stock funds seek to provide 200% long exposure on a variety of industry leaders

Others

Investment Managers Series Trust II - Tradr 2X Long CLSK Daily ETF

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$60.30
Prev Close	$62.15
Open	$68.87
Dividend Yield	N/A
50-Day Moving Average	$63.32
Beta	N/A
Avg. Volume	130,398.55
PE Ratio	N/A

52-Week High	$118.09
52-Week Low	$24.72
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

CLSX
Tradr 2X Long CLSK Daily ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CLSX News

CLSXTradr 2X Long CLSK Daily ETF